Royal Philips has launched a new image guided therapy simulation facility at its existing R&D and manufacturing facility in Best, the Netherlands.


The company has developed the new in-house simulation facility for early and continuous product design validation and end-user testing.

Philips image guided therapy general manager Bert van Meurs said: "We have combined our expertise and activities in the field of product design validation and usability testing, and expanded the team, enabling us to validate and test throughout the product creation process from early development to final product.

"Our goal is to further enhance the user experience and enable the effective and efficient use of our technology – for example during critical procedures such as the minimally-invasive treatment of a heart attack or stroke."

In October this year, Philips collaborated with Massachusetts Institute of Technology (MIT) to explore the use of its ultrasound technology and MIT physiological modeling as a less invasive way to measure intracranial pressure (ICP), an essential tool in managing patients with brain injuries.

Under the study, Philips will work with experts in the field of neurosurgery to test a core estimation algorithm that was developed by the Integrative Neuro-monitoring and Critical Care Informatics Group in MIT’s Institute for Medical Engineering and Science (IMES).

With operations in around 100 countries, Philips provides cardiac care, acute care and home healthcare services.

Image: Royal Philips has opened a new image guided therapy simulation facility in Netherlands. Photo: courtesy of Koninklijke Philips N.V.